Feb 25 (Reuters) - Oriola Oyj ORIOLA.HE:
ORIOLA Q4 EPS EUR -0.1
ORIOLA Q4 SALES EUR 502 MILLION
Q4 EBITDA WAS EUR 5.8 (7.0) MILLION INCLUDING ADJUSTING ITEMS OF EUR -4.1 (-2.4) MILLION.
PROPOSES TO ANNUAL GENERAL MEETING THAT A DIVIDEND OF EUR 0.03 (0.07) PER SHARE BE PAID FOR 2025
TO RESOLVE ON DISTRIBUTION OF A POSSIBLE SECOND DIVIDEND INSTALMENT UP TO A MAXIMUM OF EUR 0.04 PER SHARE
IN 2026, PHARMACEUTICAL DISTRIBUTION MARKET IS EXPECTED TO CONTINUE TO GROW
VALUE GROWTH IS EXPECTED TO BE DRIVEN BY HIGH-VALUE PHARMACEUTICALS AND PRODUCTS REQUIRING ADVANCED LOGISTICS.
FOR 2026, ORIOLA EXPECTS ADJUSTED EBITDA TO INCREASE FROM PREVIOUS YEAR (2025: EUR 35.1 MILLION).
EXPECTATION OF IMPROVED ADJUSTED EBITDA IS BASED ON GROWING MARKETS AND STRATEGY EXECUTION.
Source text: ID:nWkr2nxDkh
Further company coverage: ORIOLA.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))